TIVDAK (Tisotumab vedotin) approved by Japan Ministry of Health, Labour and Welfare for the treatment...

Innovent dosed first participant in Phase 3 clinical study of IBI354 (novel HER2 ADC) for...

MacroGenics pulls plug on Vobra duo ADC after seeing Phase 2 Prostate cancer data

AbbVie lawsuit alleges that partner Genmab “misappropriated” trade secrets

Eisai’s abandoned Enhertu challenger set to live on at BlissBio

GV20 Therapeutics announces collaboration agreement with Mitsubishi Tanabe Pharma Corporation to develop novel antibody-drug conjugates